Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2011

Dec 14, 2011

34301_dirs_2011-12-14_c95b385d-5f69-4fd9-90a4-c3bc368a8778.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-12-13

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-13 Common Stock P 2000 $2.22 Acquired 82559 Indirect
2011-12-13 Common Stock P 2000 $2.21 Acquired 84559 Indirect
2011-12-13 Common Stock P 1000 $2.18 Acquired 85559 Indirect
2011-12-13 Common Stock P 1000 $2.17 Acquired 86559 Indirect
2011-12-13 Common Stock P 1000 $2.15 Acquired 87559 Indirect
2011-12-13 Common Stock P 1000 $2.14 Acquired 88559 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 146101 Indirect
Common Stock 34909 Indirect

Footnotes

F1: These securities are owned by the Dave Rickey and Daughters Foundation.

F2: These securities are owned by David M Rickey, Trustee FBO The Rickey Annunity Trust.

F3: These securities are owned by Dave Rickey, TTEE FBO the David Rickey Trust